Topics

Glioblastoma | Overall management | Overview

Home > Publications > Topics > Glioblastoma > Overall management > Overview

**Fine HA.
Glioblastoma: Not Just Another Cancer.
Cancer Discov. 2024 Apr 4;14(4):648-652. doi: 10.1158/2159-8290.CD-23-1498. PMID: 38571415. Perspective˰ ˍ

*Roda D, Veiga P, Melo JB, Carreira IM, Ribeiro IP.
Principles in the Management of Glioblastoma.
Genes (Basel). 2024 Apr 17;15(4):501. doi: 10.3390/genes15040501. PMID: 38674436. Review. ˍ

Montes-Escobar K, de la Hoz-M J, Castillo-Cordova P, Duran-Ospina JP, Bravo-Saltos RK, Lapo-Talledo GJ, Siteneski A.
Glioblastoma: a comprehensive approach combining bibliometric analysis, Latent Dirichlet Allocation, and HJ-Biplot : Glioblastoma insights and trends: a 49-year bibliometric analysis.
Neurosurg Rev. 2024 May 10;47(1):209. doi: 10.1007/s10143-024-02440-x. PMID: 38724684. Bibliometric analysis˰ ˍ

Salvalaggio A, Pini L, Bertoldo A, Corbetta M.
Glioblastoma and brain connectivity: the need for a paradigm shift.
Lancet Neurol. 2024 Jun 12;23(7):740-748. doi: 10.1016/S1474-4422(24)00160-1. PMID: 38876751. Perspective˰ ˍ

Hainfellner A, Borkovec M, Seebrecht L, Neuhauser M, Roetzer-Pejrimovsky T, Greutter L, Surböck B, Hager-Seifert A, Gorka-Vom Hof D, Urbanic-Purkart T, Stultschnig M, Cijan C, Würtz F, Calabek-Wohinz B, Pichler J, Höllmüller I, Leibetseder A, Weis S, Kleindienst W, Seiberl M, Bieler L, Hecker C, Schwartz C, Iglseder S, Heugenhauser J, Nowosielski M, Thomé C, Moser P, Hoffermann M, Loibnegger K, Dieckmann K, Tomschik M, Widhalm G, Rössler K, Marosi C, Wöhrer A, Hainfellner JA, Oberndorfer S.
Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population.
J Neurooncol. 2024 Aug 27. doi: 10.1007/s11060-024-04808-x. PMID: 39192069. Observational study. ˍ

Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P, Kovács Á.
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes.
Cancers (Basel). 2025 Jan 5;17(1):146. doi: 10.3390/cancers17010146. PMID: 39796773. Review. ˍ

Le Calvez K, Mauricaite R, Treasure P, Booth TC, Price SJ, Brodbelt A, Gregory JJ, Dadhania S, Pakzad-Shahabi L, Dumba M, Oberg I, Vernon S, Basharat J, Williams M.
Adult glioblastoma in England: Incidence, treatment, and outcomes with novel population-based strata.
Cancer Epidemiol. 2025 Apr 8;97:102811. doi: 10.1016/j.canep.2025.102811. PMID: 40203511. Observational study. ˍ

Anwer MS, Abdel-Rasol MA, El-Sayed WM.
Emerging therapeutic strategies in glioblastsoma: drug repurposing, mechanisms of resistance, precision medicine, and technological innovations.
Clin Exp Med. 2025 Apr 13;25(1):117. doi: 10.1007/s10238-025-01631-0. PMID: 40223032. Review. ˍ

Politis A, Stavrinou L, Kalyvas A, Boviatsis E, Piperi C.
Glioblastoma: molecular features, emerging molecular targets and novel therapeutic strategies.
Crit Rev Oncol Hematol. 2025 May 12:104764. doi: 10.1016/j.critrevonc.2025.104764. PMID: 40368035. Review˰ ˍ

Möller C, Schoof M, Ligon KL, Schüller U.
Integration of omics data in the diagnosis and therapy of glioblastoma.
Brain Pathol. 2025 Jun 17:e70027. doi: 10.1111/bpa.70027. PMID: 40527506. Review. ˍ

Singh S, Dey D, Barik D, Mohapatra I, Kim S, Sharma M, Prasad S, Wang P, Singh A, Singh G.
Glioblastoma at the crossroads: current understanding and future therapeutic horizons.
Signal Transduct Target Ther. 2025 Jul 9;10(1):213. doi: 10.1038/s41392-025-02299-4. PMID: 40628732. Review. ˍ

Patil N, Dube S, Mutua F, Kakumanu S, Shankar JJ, Sinha N, Pareek V.
Survival Impact of Isocitrate Dehydrogenase (IDH)-Wildtype Histological Versus Molecular Glioblastoma: A Propensity Score-Matched Analysis.
Cureus. 2025 Jul 24;17(7):e88667. doi: 10.7759/cureus.88667. PMID: 40861724. Observational study. ˍ

Królikowska K, Błaszczak K, Ławicki S, Zajkowska M, Gudowska-Sawczuk M.
Glioblastoma-A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article.
Int J Mol Sci. 2025 Dec 18;26(24):12162. doi: 10.3390/ijms262412162. PMID: 41465586. Review. ˍ

Yu SP.
Editorial for the Special Issue "Glioblastoma: What Do We Know?".
Cells. 2026 Jan 21;15(2):200. doi: 10.3390/cells15020200. PMID: 41597274Editorial. ˍ

Sung JY, Hwang K.
Glioblastoma: epidemiology, molecular pathogenesis, diagnosis, management, and therapeutic resistance.
Mol Biomed. 2026 May 8;7(1):63. doi: 10.1186/s43556-026-00467-8. PMID: 42101535. ˍ

*Chaturvedi A, Poodipedi SC.
Advances in glioblastoma: Is there light at the end of the tunnel?
Indian J Med Res. 2026 Jun 10;163(6):697-699. doi: 10.25259/IJMR_1361_2026. PMID: 42295727. ˍ

Chan YB, Pang RKJ, Pang BC, Yeo TT, Tan BY.
Glioblastoma: current challenges and future horizons.
Singapore Med J. 2026 Jun 26;67(6):383-386. doi: 10.4103/singaporemedj.SMJ-2026-356. PMID: 42359712. ˍ